3 Small-Cap Biotech Stocks to Buy This Fall
Hundreds of small-cap biotech stocks are available for investors. All of them come with relatively high levels of risk. With that high risk, though, also comes the potential for high returns.
But which small-cap biotech stocks have the best risk-reward profiles? Celldex Therapeutics (NASDAQ: CLDX), Idera Pharmaceuticals (NASDAQ: IDRA), and NewLink Genetics (NASDAQ: NLNK) stand out from the crowd. Here's why these three small-cap biotech stocks could be smart picks this fall.
Image source: Getty Images.
Source: Fool.com
Merck & Co. Inc. Aktie
106,40 €
-0,56 %
Die Merck & Co. Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Ein Kursziel von 125 € für Merck & Co. Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 106.4 €.
